Can I get Wegovy if my BMI is under 27?

Wegovy is FDA-approved for adults with BMI 30+ or BMI 27+ with a weight-related condition. If your BMI is under 27, you typically won't meet eligibility criteria, and insurance won't cover it. Your doctor can discuss other options.

Does meeting BMI criteria guarantee insurance coverage?

No. Clinical eligibility and insurance coverage are separate. Even if you meet FDA criteria, your insurance may not cover weight loss medications, may require prior authorization, or may have additional requirements like documented weight loss attempts.

What's the difference between Wegovy and Ozempic?

Both contain semaglutide, but Wegovy is FDA-approved specifically for weight management (at 2.4mg dose), while Ozempic is approved for type 2 diabetes (at 1mg dose). Your doctor may prescribe Ozempic off-label for weight loss in some cases.

How much does Wegovy cost without insurance?

Wegovy's list price is approximately $1,349 per package. NovoCare offers self-pay options including limited-time starter pricing and an ongoing self-pay price. Check NovoCare.com for current offers and eligibility requirements.

What if I get denied coverage?

You can appeal the denial. Common reasons for denial include incomplete documentation or missing prior authorization. Your doctor's office can help submit additional documentation or request a peer-to-peer review with the insurance company.

Do I Qualify for Wegovy? BMI Requirements Checker

You may qualify for Wegovy if your BMI is 30 or higher, or if your BMI is 27–29.9 with at least one weight-related condition like high blood pressure, type 2 diabetes, or sleep apnea. Use the checker below to see where you stand and get a printable prep checklist for your doctor visit.

Comparing multiple medications? Use our GLP-1 Eligibility Calculator to check Wegovy, Zepbound, and compounded options side-by-side.

Last updated: January 25, 2026|Reviewed by: WPG Research Team

Wegovy Eligibility at a Glance

Your BMI	Conditions Required?	Eligibility Status
30 or higher	None required	May qualify
27 – 29.9	At least one condition	May qualify
27 – 29.9	None	Usually requires condition
Below 27	N/A	Below typical thresholds

Check Your Eligibility

Answer a few quick questions to see if you may qualify for Wegovy

Age Group

Height (feet)

Height (inches)

Weight (lbs)

Do you have any of these conditions?

These are commonly considered "weight-related conditions" for eligibility purposes.

What BMI Do You Need for Wegovy?

Wegovy is FDA-indicated for adults with obesity (BMI 30+) or adults with overweight (BMI 27-29.9) plus at least one weight-related comorbid condition such as hypertension, type 2 diabetes, or dyslipidemia.

In practice, this means: if your BMI is 30 or higher, that alone typically meets the indication. If your BMI is between 27 and 29.9, you'll generally need a qualifying weight-related condition.

These same criteria apply whether you're seeing your primary care doctor, an endocrinologist, or using a telehealth platform.

Note: This page focuses on adult criteria. Wegovy is also FDA-approved for pediatric patients aged 12+ with obesity—criteria differ, so consult a clinician for pediatric use.

What Conditions Help You Qualify?

If your BMI is between 27 and 29.9, you may qualify with one of these weight-related conditions:

High blood pressure

Most common qualifying condition

High cholesterol

Including high LDL or low HDL

Type 2 diabetes

GLP-1s were originally developed for diabetes

Sleep apnea

Strongly linked to weight

Cardiovascular disease

Heart disease, prior heart attack, or stroke

Note: Having one of these conditions doesn't guarantee insurance coverage—it's a clinical eligibility criterion, not an insurance criterion. Your insurer may have additional requirements.

What If My BMI Is Between 27 and 30?

This is the "gray zone" where eligibility depends on having a weight-related condition.

If you have a condition

You likely meet clinical criteria. Bring documentation of your diagnosis (medications you take, recent lab work, etc.) to your appointment.

If you don't have a documented condition

Most insurers and clinical guidelines won't consider you eligible. However, you may have a condition you don't know about—many people discover high blood pressure or prediabetes during routine checkups.

Doctor Visit Prep Checklist

If you think you may qualify, here's what to bring to your appointment:

Documents to Gather

Recent weight history (if you've tracked it)
List of weight-related conditions with diagnosis dates
Previous weight loss attempts (programs, medications, dates)
Current medications list
Recent lab work (if available)

Questions for Your Doctor

Am I a candidate for GLP-1 medication based on my health history?
Which medication would you recommend and why?
What side effects should I expect?
How will we monitor my progress?
Will you help with prior authorization if needed?

Questions for Insurance

Is Wegovy covered under my plan?
Is prior authorization required?
What documentation do you need?
Are there step therapy requirements?
What's my expected copay/coinsurance?

Ready to Take the Next Step?

Talk to Your Own Doctor

Your primary care doctor or endocrinologist can evaluate you, prescribe Wegovy, and help with insurance prior authorization. Bring the checklist above.

Check Your Insurance Coverage

Call the number on your insurance card or use Novo Nordisk's coverage checker to see if Wegovy is covered under your plan.

NovoCare Coverage Tool

Consider Telehealth Options

If you prefer online access or your doctor doesn't prescribe weight loss medications, telehealth platforms can connect you with licensed providers.

Compare Providers

Frequently Asked Questions

Sources

Medical Disclaimer

This tool provides general information based on publicly available FDA criteria. It is not medical advice and does not replace consultation with a licensed healthcare provider. Only a qualified clinician can determine if Wegovy or any medication is appropriate for your individual situation. Always discuss medications with your doctor before starting treatment.